Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Mont

Showing results (11-20 of 1,407) with videos related to

Pageof 141
Sort By:
Lancet (London, England)|February 21, 2019
Survival of total hip replacementsNipun Sodhi, Michael A Mont
The Journal of Arthroplasty|June 10, 2019
Does Patient Experience After a Total Knee Arthroplasty Predict Readmission?Nipun Sodhi, Michael A Mont,
The Journal of Arthroplasty|March 25, 2014
Dealing with recalled componentsSamik Banerjee, Michael A Mont
The Journal of Bone and Joint Surgery. American Volume|May 3, 2003
Sequelae of Hylan G-F 20 viscosupplementation of the kneeMichael A Mont, Gracia Etienne
Lancet (London, England)|October 1, 2013
Total hip replacement: mortality and risksKimona Issa, Michael A Mont
The Journal of Arthroplasty|October 15, 2025
International Consensus Meeting 2025: Did We Need Another One?Javad Parvizi, Michael A Mont
Clinical Orthopaedics and Related Research|March 13, 2018
CORR Insights®: Risk of Complications After THA Increases Among Patients Who Are Coinfected With HIV and Hepatitis CAnton Khlopas, Michael A Mont
The Journal of Arthroplasty|October 9, 2025
A Rebuttal to Conrad et al.'s "Commentary on 'A Phase 3 Active-Controlled Trial of Liposomal Bupivacaine via Adductor Canal Block for Total Knee Arthroplasty'"Michael A Mont, Joseph Marino
Surgical Technology International|August 17, 2021
Chlorhexidine Cloth Overview for Surgical Infection PreventionZhongming Chen, Michael A Mont
The Journal of Arthroplasty|October 9, 2025
Bridging Disciplines: A Commentary on the Phase 3 Trial of Liposomal Bupivacaine via Adductor Canal Block for Total Knee ArthroplastyMichael A Mont, Joseph Marino
Pageof 141

Showing results (11-20 of 1,407) with videos related to

Sort By:
Pageof 141
Lancet (London, England)|February 21, 2019
Survival of total hip replacementsNipun Sodhi, Michael A Mont
The Journal of Arthroplasty|June 10, 2019
Does Patient Experience After a Total Knee Arthroplasty Predict Readmission?Nipun Sodhi, Michael A Mont,
The Journal of Arthroplasty|March 25, 2014
Dealing with recalled componentsSamik Banerjee, Michael A Mont
The Journal of Bone and Joint Surgery. American Volume|May 3, 2003
Sequelae of Hylan G-F 20 viscosupplementation of the kneeMichael A Mont, Gracia Etienne
Lancet (London, England)|October 1, 2013
Total hip replacement: mortality and risksKimona Issa, Michael A Mont
The Journal of Arthroplasty|October 15, 2025
International Consensus Meeting 2025: Did We Need Another One?Javad Parvizi, Michael A Mont
Clinical Orthopaedics and Related Research|March 13, 2018
CORR Insights®: Risk of Complications After THA Increases Among Patients Who Are Coinfected With HIV and Hepatitis CAnton Khlopas, Michael A Mont
The Journal of Arthroplasty|October 9, 2025
A Rebuttal to Conrad et al.'s "Commentary on 'A Phase 3 Active-Controlled Trial of Liposomal Bupivacaine via Adductor Canal Block for Total Knee Arthroplasty'"Michael A Mont, Joseph Marino
Surgical Technology International|August 17, 2021
Chlorhexidine Cloth Overview for Surgical Infection PreventionZhongming Chen, Michael A Mont
The Journal of Arthroplasty|October 9, 2025
Bridging Disciplines: A Commentary on the Phase 3 Trial of Liposomal Bupivacaine via Adductor Canal Block for Total Knee ArthroplastyMichael A Mont, Joseph Marino
Pageof 141